SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (919)7/10/1997 2:54:00 AM
From: JOHN W.   of 6136
 
Not to mislead others as David S. does. My reliable source is my broker who strongly believes AGPH is a strong takeover candidate despite the poison pill (maybe just 49% is another option). But you now know of the true character of sell side analyst from David, maybe my broker is just listening to one of these scoundrels. Just look at David's comparison of side effects...He knows nothing of protease inhibitors. So what if 30% have to buy Imodium for a couple of days, it should'nt even be an issue.

P.S. Look out for positive earnings anouncements from AMGN and large Drug stocks the next couple of weeks, starting today. Today could be the last buying opportunity before 100.

Regards, John.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News